lung disease
Conditions
Interventions
Experimental group:Transcutaneous Electrical Acupoint Stimulation
Sponsors
Hebei General Hospital
Eligibility
Sex/Gender
All
Age
25 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients who intend to undergo thoracoscopic surgery under general anesthesia; 2. Aged 25-70 years, gender and weight are not limited; 3. American Society of Anesthesiologists ASA classification I-III, no history of serious systemic diseases; 4. The operation time is estimated to be about 2 hours; 5. Those who agree to accept this trial and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Those who have local infection or chronic inflammation on the surface of the acupoint stimulation site, or who cannot stick electrode pads; 2. The adjacent nerves of acupoints such as median, ulnar and radial nerves are confirmed to have functional impairment and hypoesthesia due to cervical spondylosis or trauma; 3. It is expected that there is a difficult airway (such as abnormal airway grading, menthol spacing, mouth opening, etc.) or difficult extubation or short-term failure to extubate the tube due to the patient's own factors; 4. Those who have recently received acupoint stimulation or treatment or have been significantly insensitive to acupoint stimulation treatment in the past; 5. Severe lung infection, bronchial inflammation, high airway response, and large amount of sputum are expected to have a greater impact on postoperative extubation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Interleukin 6;Interleukin 10; | — |
Countries
China
Contacts
Public ContactMeng Xiangshuo
Hebei General Hospital
Outcome results
None listed